Workflow
Hengtong(600226)
icon
Search documents
亨通股份: 浙江亨通控股股份有限公司对外担保管理制度
Zheng Quan Zhi Xing· 2025-08-25 16:30
浙江亨通控股股份有限公司 对外担保管理制度 第一章 总 则 第一条 为规范浙江亨通控股股份有限公司(以下简称"公司")的对外担保 行为,有效防范公司对外担保风险,保护公司资产安全,维护股东利益,根据《中华 人民共和国公司法》(以下简称"《公司法》")、《中华人民共和国证券法》(以下 简称"《证券法》")、 第三条 公司对外担保实行统一管理,未经公司董事会或股东会审议批准,任 何人无权以公司名义签署对外担保的合同、协议或其他类似的法律文件。 《中华人民共和国民法典》 (以下简称"《民法典》")、 《上市 公司监管指引第 8 号——上市公司资金往来、对外担保的监管要求》 《上海证券交 易所股票上市规则》 (以下简称"《股票上市规则》")及《上海证券交易所上市 公司自律监管指引第 1 号——规范运作》等法律、法规和规范性文件以及《浙江 亨通控股股份有限公司章程》(以下简称"《公司章程》")的有关规定和公司实 际情况,特制定本制度。 第二条 本制度所称对外担保,是指公司为他人提供的担保,包括公司对控股 子公司的担保。担保形式包括保证、抵押、质押或其他形式的担保。具体种类包 括但不限于借款担保、银行开立信用证和银行承兑 ...
亨通股份: 浙江亨通控股股份有限公司董事会薪酬与考核委员会实施细则
Zheng Quan Zhi Xing· 2025-08-25 16:30
浙江亨通控股股份有限公司 董事会薪酬与考核委员会实施细则 第一章 总 则 第一条 为进一步建立健全浙江亨通控股股份有限公司(以下简称"公司") 董事及高级管理人员的考核和薪酬管理制度,完善公司治理结构,根据《中华人民 共和国公司法》《上市公司独立董事管理办法》《上海证券交易所股票上市规则》 《上海证券交易所上市公司自律监管指引第1号——规范运作》《浙江亨通控股股 份有限公司章程》(以下简称"《公司章程》")及其他有关规定,公司特设立董 事会薪酬与考核委员会,并制定本实施细则。 第二条 薪酬与考核委员会主要负责制定公司董事及高级管理人员的考核标准 并进行考核;负责制定、审查公司董事及高级管理人员的薪酬政策与方案,对董事 会负责。 第三条 本细则所称董事是指在本公司支取薪酬的董事,高级管理人员是指董 事会聘任的总裁、副总裁、财务总监、董事会秘书及由《公司章程》认定的其他高 级管理人员。 第二章 人员组成 第四条 薪酬与考核委员会成员由3名董事组成,其中独立董事2名。 第五条 薪酬与考核委员会委员由董事会选举产生。 第六条 薪酬与考核委员会设召集人一名,由独立董事委员担任,负责主持委 员会工作;召集人在委员内选举, ...
亨通股份: 浙江亨通控股股份有限公司独立董事年报工作制度
Zheng Quan Zhi Xing· 2025-08-25 16:30
浙江亨通控股股份有限公司 独立董事年报工作制度 第一章 总则 第一条 为进一步完善浙江亨通控股股份有限公司(以下简称"公司")的 治理机制,加强内部控制建设,进一步提高公司信息披露质量,充分发挥独立董 事在年度报告编制、披露工作中的作用,根据《上市公司独立董事管理办法》 《上 海证券交易所股票上市规则》《上海证券交易所上市公司自律监管指引第1号— —规范运作》等规范性文件和《浙江亨通控股股份有限公司章程》《浙江亨通控 股股份有限公司独立董事工作制度》等规定,结合公司实际情况,特制定本制度。 第二条 独立董事应在公司年度报告(以下简称"年报")编制和披露过程 中,切实履行独立董事的责任和义务,勤勉尽责地开展工作。 第三条 在公司年报编制期间,独立董事负有保密义务。在公司年报公布前, 不得以任何形式向外界泄漏年度报告的内容,杜绝内幕交易等违法违规行为。 第二章 具体规定 第四条 每个会计年度结束后30日内,公司管理层应向独立董事全面汇报公 司本年度的生产经营情况和重大事项的进展情况,并安排独立董事进行实地考察。 上述事项应有书面记录,必要的文件应有当事人签字。 第七条 在年审会计师出具初步审计意见后、公司召开年度 ...
亨通股份: 浙江亨通控股股份有限公司董事会战略委员会实施细则
Zheng Quan Zhi Xing· 2025-08-25 16:30
Core Viewpoint - The establishment of the Strategic Committee by Zhejiang Hengtong Holdings Co., Ltd. aims to enhance the company's core competitiveness and improve the quality of major investment decisions [1][2]. Group 1: Committee Structure - The Strategic Committee consists of 5 directors elected by the board [3]. - The chairman of the company serves as the convener of the Strategic Committee [4]. - The term of the Strategic Committee aligns with that of the board, allowing for re-election [5]. Group 2: Responsibilities and Authority - The committee is responsible for researching and proposing suggestions on the company's long-term development strategy and major investment decisions [1][8]. - It reviews significant investment financing plans and major capital operations that require board approval [8]. - The committee checks the implementation of the aforementioned matters and handles other authorized affairs [8]. Group 3: Decision-Making Process - An Investment Review Group prepares preliminary work for the Strategic Committee's decisions, including feasibility reports and basic information about partners [2][10]. - The committee discusses proposals from the Investment Review Group and submits the results to the board [11]. - Meetings require attendance from at least two-thirds of the committee members to be valid, with decisions made by a majority vote [12][13]. Group 4: Meeting Procedures - Meetings can be called as needed, with notifications sent five days in advance, although this can be waived in urgent situations [12]. - The committee can invite external experts for professional opinions, with confidentiality agreements in place [16]. - Meeting records must be kept for at least ten years, and all attendees are bound by confidentiality [18][20]. Group 5: Implementation and Interpretation - The implementation rules take effect upon approval by the board [21]. - Any unresolved matters will follow national laws and the company's articles of association [22]. - The board holds the authority to interpret these implementation rules [23].
亨通股份: 浙江亨通控股股份有限公司董事会议事规则
Zheng Quan Zhi Xing· 2025-08-25 16:30
浙江亨通控股股份有限公司 董事会议事规则 第一条 宗旨 为了进一步规范浙江亨通控股股份有限公司(以下简称"公司"或"本公 司")董事会的议事方式和决策程序,促使公司董事和董事会有效地履行其职责, 提高公司董事会规范运作和科学决策水平,根据《公司法》《证券法》《上市公 司治理准则》《上海证券交易所股票上市规则》等有关规定和《浙江亨通控股股 份有限公司章程》(以下简称"《公司章程》"),制定本规则。 第二条 董事会日常事务处理部门 董事会下设董事会办公室,处理董事会日常事务。董事会秘书负责保管董事 会印章。 第三条 定期会议 董事会会议分为定期会议和临时会议。 董事会每年应当至少召开两次定期会议。 第四条 定期会议的提案 在发出召开董事会定期会议的通知前,董事会办公室应当充分征求各董事的 意见,初步形成会议提案后交董事长拟定。 董事长在拟定提案前,应当视需要征求总裁和其他高级管理人员的意见。 第五条 临时会议 有下列情形之一的,董事会应当召开临时会议: (一)代表十分之一以上表决权的股东提议时; 第六条 临时会议的提议程序 按照前条规定提议召开董事会临时会议的,应当通过董事会办公室或者直接 向董事长提交经提议人签 ...
亨通股份: 浙江亨通控股股份有限公司关联交易决策权限与程序规则
Zheng Quan Zhi Xing· 2025-08-25 16:30
浙江亨通控股股份有限公司 关联交易决策权限与程序规则 第一章 总则 第一条 为规范浙江亨通控股股份有限公司(以下简称"公司")关联交易行 为,保护公司和投资者的合法权益,根据《中华人民共和国公司法》 (以下简称"《公 司法》")、《中华人民共和国证券法》(以下简称"《证券法》")、《上海证 券交易所股票上市规则》(以下简称"《股票上市规则》")、《上海证券交易所 上市公司自律监管指引第 5 号——交易与关联交易》等有关法律、法规、规范性文 件以及《浙江亨通控股股份有限公司章程》(以下简称"《公司章程》")的有关 规定,制定本规则。 第二条 公司进行关联交易应遵循以下基本原则: (一)诚实信用原则; (二)平等、自愿、等价、有偿的原则; (三)公正、公平、公开的原则。关联交易的价格或收费原则上应不偏离市场 独立第三方的标准,对于难以比较市场价格或订价受到限制的关联交易,应通过合 同明确有关成本和利润的标准。公司应对关联交易的定价依据予以充分披露; (四)关联股东及董事回避原则; (五)公司董事会应当根据客观标准判断关联交易是否对公司有利,必要时应 当聘请证券律师、专业评估师或独立财务顾问发表意见。 第三条 公司 ...
亨通股份: 浙江亨通控股股份有限公司募集资金使用管理办法
Zheng Quan Zhi Xing· 2025-08-25 16:30
浙江亨通控股股份有限公司 募集资金使用管理办法 第一章 总则 第一条 为规范浙江亨通控股股份有限公司(以下简称"公司")募集资金 的管理和使用,保护投资者利益,根据《中华人民共和国公司法》《中华人民共 和国证券法》《上市公司证券发行管理办法》《上海证券交易所股票上市规则》 (以下简称"《股票上市规则》")、《上市公司募集资金监管规则》《上海证 券交易所上市公司自律监管指引第 1 号——规范运作》等法律法规、规范性文件 以及《浙江亨通控股股份有限公司章程》(以下简称"《公司章程》")的规定, 并结合公司实际情况,特制定本办法。 第二条 本办法所称募集资金是指公司通过发行股票或者其他具有股权性质 的证券,向投资者募集并用于特定用途的资金监管,但不包括公司实施股权激励 计划募集的资金监管。 公司董事会应当对募集资金投资项目(以下简称"募投项目")的可行性进 行充分论证,确信投资项目具有较好的市场前景和盈利能力,有效防范投资风险, 提高募集资金使用效益。 第三条 公司对募集资金的管理遵循专户存放、专款专用、严格管理、如实 披露的原则。公司董事会负责建立并完善募集资金存储、使用和管理的内部控制 制度,对募集资金存储、使 ...
亨通股份: 浙江亨通控股股份有限公司2025年半年度报告
Zheng Quan Zhi Xing· 2025-08-25 16:30
Core Viewpoint - Zhejiang Hengtong Holding Co., Ltd. reported a significant increase in revenue and net profit for the first half of 2025, driven primarily by the growth in copper foil sales and steam business profits [2][12][13]. Company Overview and Key Financial Indicators - The company achieved an operating income of 818.21 million yuan, a year-on-year increase of 45.80% [2][12]. - The total profit reached 140.72 million yuan, up 16.68% from the previous year [2][12]. - The net profit attributable to shareholders was 126.95 million yuan, reflecting an 8.91% increase [2][12]. - The company's total assets grew by 7.07% to 4.81 billion yuan, while net assets increased by 3.96% to 3.55 billion yuan [2][12]. Industry and Main Business Situation - The company's revenue primarily comes from the production and sales of electrolytic copper foil, veterinary drugs, and feed additives, as well as combined heat and power supply [12][13]. - The electrolytic copper foil market is expected to grow due to increasing demand from the PCB industry and the rise of AI applications, which require high-performance materials [12][13]. - The global PCB market is projected to grow at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2029, reaching approximately 94.66 billion USD by 2029 [12][13]. - The lithium battery copper foil market is also expanding, driven by the growth of the new energy vehicle sector and energy storage systems [12][13]. Business Performance and Development - The company’s subsidiary, Hengtong Copper Foil, has successfully developed high-value-added products such as reverse copper foil (RTF) and low-profile copper foil (LP), which are now in mass production [12][13]. - The company is actively expanding its market presence and enhancing its product offerings in high-end copper foil products to meet the increasing demands of the electronics industry [12][13]. - The company is investing in a small variety amino acid production base, which will add 11,880 tons/year of production capacity, enhancing its competitive position in the amino acid market [12][15]. Research and Development - Hengtong Copper Foil has established a robust R&D framework, collaborating with renowned universities to innovate and improve product quality [12][19]. - The company has applied for 70 patents and received 25 authorizations, indicating a strong commitment to technological advancement and intellectual property protection [12][19]. Market Trends - The demand for feed additives, particularly amino acids, is expected to grow due to the increasing focus on animal nutrition and the reduction of soybean meal in feed formulations [12][7]. - The veterinary drug market is also expanding, with the company focusing on international markets, particularly in South America and Asia [12][16].
亨通股份: 浙江亨通控股股份有限公司2025年半年度报告摘要
Zheng Quan Zhi Xing· 2025-08-25 16:30
Core Viewpoint - Zhejiang Hengtong Holdings Co., Ltd. reported significant growth in revenue and total assets for the first half of 2025, indicating a strong operational performance despite a decline in net profit attributable to shareholders [1][2]. Financial Performance - Total assets increased to CNY 4,813.56 million, up 7.07% from the previous year [1]. - Operating revenue reached CNY 818.21 million, representing a 45.80% increase compared to the same period last year [1]. - Total profit amounted to CNY 140.72 million, a 16.68% rise year-on-year [1]. - Net profit attributable to shareholders decreased by 29.36% to CNY 78.33 million, excluding non-recurring gains and losses [1]. Cash Flow and Shareholder Information - The net cash flow from operating activities was negative at CNY -62.05 million, compared to CNY -48.74 million in the previous year [1]. - The total number of shareholders as of the reporting period was 34,237 [1]. Major Shareholders - Hengtong Group Co., Ltd. holds 16.95% of the shares, amounting to 504,153,332 shares, and is the controlling shareholder [2]. - Other significant shareholders include Suzhou Hengtong Yongxu Venture Capital with 10.83% and Zhangjiagang Puxin Enterprise Management Consulting with 5.24% [2]. Important Developments - The company is set to enhance its production capacity with the completion of a small amino acid production base project, which will add 11,880 tons/year of production capacity, including L-Tryptophan and L-Arginine [5].
亨通股份上半年营收同比增长45.80% 铜箔业务聚焦高端化成效显著
Core Viewpoint - Hengtong Holdings reported significant growth in revenue and net profit for the first half of 2025, driven primarily by its copper foil business, which is positioned as a key growth engine for the company [1][2]. Financial Performance - The company achieved a revenue of 818 million yuan, representing a year-on-year increase of 45.80% - Net profit attributable to shareholders was 127 million yuan, up 8.91% year-on-year [1]. Business Segments - The copper foil business contributed 553 million yuan in revenue, accounting for 67.59% of total revenue, with sales volume increasing by 131.33% [1]. - The company has a production capacity of 10,000 tons/year for electronic circuit copper foil and 5,000 tons/year for lithium battery copper foil, with ongoing construction to expand capacity [3]. Market Demand and Trends - The demand for electronic circuit copper foil is closely linked to the rapid development of AI computing power, 5G communication, and new energy vehicles, with a projected compound annual growth rate of 5.2% for global PCB output from 2024 to 2029 [1][2]. - The lithium battery copper foil market is driven by the needs of new energy vehicles and energy storage systems, with increasing demands for higher energy density and longer battery life [1]. Strategic Direction - Hengtong Holdings is focusing on high-end copper foil products, avoiding price wars, and emphasizing R&D and industrial application to capture domestic substitution opportunities [2]. - The company has developed high-value-added products such as RTF, LP, and HTE copper foils, which have already entered mass production [2]. Production and Supply Chain - The company’s production base in Deyang, Sichuan, benefits from local sulfuric acid resources and copper material storage advantages, which help reduce production and transportation costs [3]. - Hengtong Holdings is strengthening partnerships with leading PCB manufacturers, with products being increasingly adopted by major clients [2][3]. Other Business Developments - In addition to copper foil, the company is advancing in the biosynthesis sector, with a project in Inner Mongolia expected to add 11,880 tons/year of amino acid production capacity [3]. - The export performance of products like Monensin is strong, with a 23.50% year-on-year increase in sales [3].